1 May 2023 false No description of principal activity Taxfiler 2024.6 07623918business:PrivateLimitedCompanyLtd2023-05-012024-04-30 076239182023-04-30 076239182023-05-012024-04-30 07623918business:AuditExempt-NoAccountantsReport2023-05-012024-04-30 07623918business:AbridgedAccounts2023-05-012024-04-30 076239182024-04-30 076239182023-04-30 07623918core:WithinOneYear2024-04-30 07623918core:WithinOneYear2023-04-30 07623918core:ShareCapitalcore:PreviouslyStatedAmount2024-04-30 07623918core:ShareCapitalcore:PreviouslyStatedAmount2023-04-30 07623918core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-04-30 07623918core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-04-30 07623918core:PreviouslyStatedAmount2024-04-30 07623918core:PreviouslyStatedAmount2023-04-30 07623918business:SmallEntities2023-05-012024-04-30 07623918business:Director12023-05-012024-04-30 07623918countries:EnglandWales2023-05-012024-04-30 07623918business:RegisteredOffice2023-05-012024-04-30 07623918core:PlantMachinery2023-05-012024-04-30 076239182022-05-012023-04-30 iso4217:GBP xbrli:pure
Company Registration No. 07623918 (England and Wales)
OVAL PHARMACY LTD Unaudited accounts for the year ended 30 April 2024
OVAL PHARMACY LTD Unaudited accounts Contents
Page
- 2 -
OVAL PHARMACY LTD Statement of financial position as at 30 April 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
400,000 
400,000 
Tangible assets
2,001 
2,001 
402,001 
402,001 
Current assets
Inventories
53,971 
48,590 
Debtors
76,751 
89,397 
Cash at bank and in hand
53,589 
81,533 
184,311 
219,520 
Creditors: amounts falling due within one year
(87,099)
(117,106)
Net current assets
97,212 
102,414 
Net assets
499,213 
504,415 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
499,113 
504,315 
Shareholders' funds
499,213 
504,415 
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 31 October 2024 and were signed on its behalf by
Lyakat Gulamhusein Jaffer Director Company Registration No. 07623918
- 3 -
OVAL PHARMACY LTD Notes to the Accounts for the year ended 30 April 2024
1
Statutory information
OVAL PHARMACY LTD is a private company, limited by shares, registered in England and Wales, registration number 07623918. The registered office is 111A HIGH STREET, WEALDSTONE, HARROW, MIDDLESEX, HA3 5DL.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20%
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Total 
£ 
Cost
At 1 May 2023
400,000 
At 30 April 2024
400,000 
Amortisation
At 1 May 2023
- 
At 30 April 2024
- 
Net book value
At 30 April 2024
400,000 
At 30 April 2023
400,000 
- 4 -
OVAL PHARMACY LTD Notes to the Accounts for the year ended 30 April 2024
5
Tangible fixed assets
Total 
£ 
Cost or valuation
At 1 May 2023
40,125 
At 30 April 2024
40,125 
Depreciation
At 1 May 2023
38,124 
At 30 April 2024
38,124 
Net book value
At 30 April 2024
2,001 
At 30 April 2023
2,001 
6
Average number of employees
During the year the average number of employees was 10 (2023: 10).
- 5 -